Registry of Local Recurrences After Breast-conserving Surgery
ConditionBreast Cancer Recurrent
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversidade do Porto
About this trial
The ReLoCC project is a prospective, multicenter, clinical study to register cases of local recurrence after breast-conserving surgery, in centers dedicated to the treatment of breast cancer, in Portugal and Spain.
The comparison of the results obtained will allow the optimization of the treatment, making it increasingly personalized.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Female patients
Age > 18 years
Patients who have previously undergone breast-conserving surgery as part of the treatment of invasive or non-invasive (in situ) breast cancer
and adjuvant breast RT: total (WBI) or partial (PBI)
Disqualifiers
Male
Age < 18 years
Stage 4 at diagnosis
Patients operated outside the participating Centers and for whom it is not possible to obtain complete information regarding the primary treatment
Trial population
Patients with local recurrence after breast-conserving surgery
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Determine prevalence of local recorrence of breast cancer after conserving surgery in Portugal and Spain
Number of cases per year
Time frame
2 years2
Follow-up of recurrences up to 5 years after treatment of first recurrence
Number of cases per year
Time frame
5 yearsSecondary outcomes
1
Identification of risk factors for local recurrence
Frequency of risk factors
Time frame
On inclusion time (2 years)2
Identification of predictive and response factors
Frequency of predictive factors
Time frame
On inclusion time (2 years)3
Determination of surgical morbidity of relapse treatment in follow up
Identification of surgical morbidity
Time frame
From date of treatment until 30 days after treatment4
Assessment of patient quality of life
Validated questionnaire for quality of life by EORTC QLQ-C30-BR23
Time frame
First and second year after treatmentLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Universidade do Porto
Lead sponsor
Centro Hospitalar De São João, E.P.E.
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: